Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $778.14 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $218.80 | 3 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $148.63 | 2 | $0 (2019) |
| PTC Therapeutics, Inc. | $128.59 | 1 | $0 (2023) |
| PFIZER PHARMACEUTICALS LLC | $114.40 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $62.29 | 1 | $0 (2018) |
| Johnson and Johnson International | $43.85 | 1 | $0 (2018) |
| Boston Scientific Corporation | $41.25 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $20.33 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.93 | 2 | Janssen Pharmaceuticals, Inc ($20.33) |
| 2023 | $128.59 | 1 | PTC Therapeutics, Inc. ($128.59) |
| 2019 | $287.92 | 3 | PFIZER PHARMACEUTICALS LLC ($114.40) |
| 2018 | $303.66 | 5 | GlaxoSmithKline, LLC. ($95.76) |
| 2017 | $23.04 | 1 | GlaxoSmithKline, LLC. ($23.04) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: General - EP_EP | ||||||
| 08/03/2023 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Food and Beverage | In-kind items and services | $128.59 | General |
| Category: DMD | ||||||
| 05/23/2019 | PFIZER PHARMACEUTICALS LLC | TRUMENBA (Biological) | Food and Beverage | In-kind items and services | $114.40 | General |
| Category: VACCINES | ||||||
| 03/21/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: VACCINES | ||||||
| 01/17/2019 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $73.52 | General |
| Category: VACCINE | ||||||
| 10/25/2018 | Johnson and Johnson International | HARMONIC Product Family (Device), ATTUNE | Food and Beverage | In-kind items and services | $43.85 | General |
| Category: Energy | ||||||
| 05/31/2018 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $75.11 | General |
| Category: VACCINE | ||||||
| 05/01/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $95.76 | General |
| Category: VACCINES | ||||||
| 04/07/2018 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: STRUCTURAL HEART | ||||||
| 03/15/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $62.29 | General |
| Category: Cardiovascular | ||||||
| 05/12/2017 | GlaxoSmithKline, LLC. | MENVEO (Biological), BEXSERO, PEDIARIX | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: VACCINES | ||||||
About Dr. Kenneth Rivera Ayala, MD
Dr. Kenneth Rivera Ayala, MD is a Pediatrics healthcare provider based in Coto Laurel, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316908007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Rivera Ayala, MD has received a total of $778.14 in payments from pharmaceutical and medical device companies, with $34.93 received in 2024. These payments were reported across 12 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($778.14).
Practice Information
- Specialty Pediatrics
- Location Coto Laurel, PR
- Active Since 03/31/2006
- Last Updated 11/26/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1316908007
Products in Payments
- BEXSERO (Biological) $195.76
- GARDASIL (Biological) $148.63
- EMFLAZA (Drug) $128.59
- TRUMENBA (Biological) $114.40
- ELIQUIS (Drug) $62.29
- HARMONIC Product Family (Device) $43.85
- WATCHMAN (Device) $26.65
- MENVEO (Biological) $23.04
- XARELTO (Drug) $20.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.